工业大麻EMS突变体及大麻素合成相关基因表达分析
作者:
作者单位:

1.湖南科技职业学院药学院;2.中国农业科学院麻类研究所

作者简介:

通讯作者:

中图分类号:

基金项目:

湖南省自然科学基金部门联合基金(2023JJ60211);国家自然科学基金青年基金(32200219)


Construction of the EMS Mutant Library for Industrial Hemp and Expression of Genes Related to Cannabinoid Biosynthesis
Author:
Affiliation:

1.School of Pharmacy,Hunan Vocational College of science and technology;2.Institute of Bast Fiber Crops,Chinese Academy of Agricultural Sciences

Fund Project:

Natural Science Foundation of Hunan Province China(2023JJ60211); National Natural Science Foundation of China (32200219)

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    工业大麻(Cannabis sativa L.)是一种应用在造纸、医疗保健、纺织等领域的高价值经济作物。创制工业大麻新种质是开展品种选育、创新种质资源、开展功能基因组研究的重要基础。本试验利用甲基磺酸乙醋(EMS)构建了中大麻资4号的突变体群体。通过设置8个EMS诱变剂浓度梯度处理,明确了0.8%EMS处理浓度对中大麻资4号诱变效果最好。对2000粒中大麻资4号种子进行诱变后,M1共成苗644株,出苗率为32.2%,其中包括叶色、花序和株高变异单株90株,突变率为13.98%。对M1突变体进行大麻二酚(CBD)含量测定,获得3个高CBD和2个低CBD含量突变株;通过测序发现CBD含量突变体中5个大麻素关键催化酶基因(CsPT4-EXP、CsOAC1-EXP、CsOLS1-EXP、CsCBDAS-EXP和CsTHCA-EXP)及其启动子区域DNA序列均未发生突变,但是CBD含量突变体中以上5个催化酶的表达水平较对照出现显著变化。由此推断,EMS处理导致了突变体中影响CBD代谢途径的调控基因突变进而调控CBD合成途径催化酶的表达,最终表现为突变体花头中CBD含量显著变化。本研究通过创制EMS突变体群体为工业大麻育种提供了优异种质资源,也为进一步解析大麻素合成代谢途径的调控机制及挖掘相关基因提供良好材料和基础。

    Abstract:

    Industrial hemp (Cannabis sativa L.) is a high-value economic crop used in papermaking, healthcare, textiles, and other fields. Developing new germplasm of industrial hemp is essential for breeding, innovative germplasm resources, and functional genomic research. In this study, a mutant library of ZHONGDAMAZI 4 (ZD4) was constructed using ethyl methanesulfonate (EMS). By setting up gradients of eight concentrations of EMS, it was determined that the 0.8% EMS treatment concentration had the best mutagenic effect on ZD4. After mutagenizing 2000 seeds of ZD4, a total of 644 M1 seedlings emerged, with an emergence rate of 32.2%. Among them, 90 individual plants exhibited variations in leaf color, inflorescence, and plant height, with a mutation rate of 13.98%. High-performance liquid chromatography (HPLC) was used to determine the cannabidiol (CBD) content of the M1 plants, resulting in the identification of 3 high-CBD and 2 low-CBD mutants. Sequencing revealed that the DNA sequences as well as the promoter regions of five key cannabinoid biosynthetic enzyme genes (CsPT4, CsOAC1, CsOLS1, CsCBDAS, and CsTHCA) in the CBD content mutants remained unchanged. However, the expression levels of these five enzymes showed significant changes compared to the control. It is inferred that EMS treatment led to mutations in regulatory genes affecting the CBD metabolic pathway in mutants, thereby regulating the expression of enzymes, ultimately resulting in significant changes in CBD content. This study provides excellent germplasm resources for industrial hemp breeding through the construction of an EMS mutant library and lays a solid foundation for further elucidating the regulatory mechanisms of cannabinoid biosynthesis and related genes.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2024-04-30
  • 最后修改日期:2024-06-21
  • 录用日期:2024-10-10
  • 在线发布日期: 2024-10-11
  • 出版日期:
您是第位访问者
ICP:京ICP备09069690号-23
京ICP备09069690号-23
植物遗传资源学报 ® 2024 版权所有
技术支持:北京勤云科技发展有限公司